Q: Can I have your thoughts on Abbvie for a 2 year hold, Many Thanks, Peter
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Can you recommend the best value Healthcare/Pharma in the US right now - looking for a value play with a bit of dividend and a bit of growth.
Thanks
Thanks
Q: Can I please get your opinion of AbbVie.
Thanks
Dave
Thanks
Dave
-
AbbVie Inc. (ABBV $210.40)
-
Enbridge Inc. (ENB $66.45)
-
CCL Industries Inc. Unlimited Class B Non-Voting Shares (CCL.B $82.27)
-
Algonquin Power & Utilities Corp. (AQN $7.96)
-
Transcontinental Inc. Class B Multiple Voting Shares (TCL.B $20.14)
-
Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD $16.98)
Q: Hello 5i,
I need to increase the following: ABBVIE, CCL, AQN. ENB. LSPD. and TCL. Some like LSPD I hold as a satellite as I am mostly a value investor but will take advantage of your suggestions on a good growth opportunity but smaller scale than my value equities. Please list the above in the order that I would slowly increase these holdings by $2,000 at a time.
thank you
Stanley
I need to increase the following: ABBVIE, CCL, AQN. ENB. LSPD. and TCL. Some like LSPD I hold as a satellite as I am mostly a value investor but will take advantage of your suggestions on a good growth opportunity but smaller scale than my value equities. Please list the above in the order that I would slowly increase these holdings by $2,000 at a time.
thank you
Stanley
Q: Can you comment on OSTK? After a big drop, the stock started to go up. Is it a good time to buy? I am consider adding OSTK and ABBV in my RRSP portfolio. ABBV has a high dividend yield. I think it would be great hold in RRSP account.
Thanks
Thanks
Q: Hi,
I am down ABBV (21%) and Altria (7%). I am thinking of holding them for long term. Do you see any further downside considering the economic fundamentals and future product lineup for these two companies.
Thanks
Ninad
I am down ABBV (21%) and Altria (7%). I am thinking of holding them for long term. Do you see any further downside considering the economic fundamentals and future product lineup for these two companies.
Thanks
Ninad
Q: Hi Team, been holding Abbv in my rrsp for a while now, and was down till this morning, now , taking a big loss. After this mornings news, should I buy more, ( I know you are not fans of doubling down) Can they still afford to pay their dividend? I thank you in advance! Sam
Q: Hi all,
I had limited Healthcare exposure (only from small positions in VXUS and VGRO). Recently added Abbvie and Pfizer on price weakness. Combined these 2 equal about 5% of my Holdings.
3 questions:
1-Comments on ABBV latest quarter? (Seems good)
2-Good Entry point for these companies for a long term hold?
3-Do these 2 companies compliment each other well or should I consider adding another stock or ETF for more Healthcare exposure?
Thanks as always for the great service!
I had limited Healthcare exposure (only from small positions in VXUS and VGRO). Recently added Abbvie and Pfizer on price weakness. Combined these 2 equal about 5% of my Holdings.
3 questions:
1-Comments on ABBV latest quarter? (Seems good)
2-Good Entry point for these companies for a long term hold?
3-Do these 2 companies compliment each other well or should I consider adding another stock or ETF for more Healthcare exposure?
Thanks as always for the great service!
-
AbbVie Inc. (ABBV $210.40)
-
Johnson & Johnson (JNJ $177.17)
-
Pembina Pipeline Corporation (PPL $51.87)
-
Inter Pipeline Ltd. (IPL $19.12)
Q: Good morning,
Two questions this morning. Both are would you make the switch?
I have JNJ that I bought at the $65.00 range back in 2011I think. Would you sell and switch it to ABBV?? Or stay the course?
Same goes for PPL. I have owned it for quite a while and it has gone up nice. Would you switch it to IPL or stay the course?
Thanks
Jimmy
Two questions this morning. Both are would you make the switch?
I have JNJ that I bought at the $65.00 range back in 2011I think. Would you sell and switch it to ABBV?? Or stay the course?
Same goes for PPL. I have owned it for quite a while and it has gone up nice. Would you switch it to IPL or stay the course?
Thanks
Jimmy
-
Illumina Inc. (ILMN $99.96)
-
AbbVie Inc. (ABBV $210.40)
-
Stryker Corporation (SYK $391.41)
-
Masimo Corporation (MASI $139.71)
Q: I am up on ABBV but think it is time to move on. What are your views on Stryker (SYK)? Any recommendations on other US Health stocks would be appreciated.
Q: Hi
I would like to know your evaluation about ABBV? Would you recommend buying at current price level (less than 80)
Thanks
I would like to know your evaluation about ABBV? Would you recommend buying at current price level (less than 80)
Thanks
Q: Aside from JNJ, my US portfolio has no healthcare/biotech stocks. How would you assess these two companies?
Thank you, Team!
P.S. The BNN presentation was very informative!
Thank you, Team!
P.S. The BNN presentation was very informative!
Q: Hi,
I would like to get your opinion on the following healthcare and industrial stocks I am planning to buy in equal amounts. Would you recommend any other stocks for long term investments under my registered accounts.
Healthcare:- ABBV, MDT,PFE,GILD
Industrials:- HON,ITW, UTX
CELG is at a better value currently. Would you buy that instead of ABBV ?
Appreciate your service.
Thanks
Ninad
I would like to get your opinion on the following healthcare and industrial stocks I am planning to buy in equal amounts. Would you recommend any other stocks for long term investments under my registered accounts.
Healthcare:- ABBV, MDT,PFE,GILD
Industrials:- HON,ITW, UTX
CELG is at a better value currently. Would you buy that instead of ABBV ?
Appreciate your service.
Thanks
Ninad
Q: How old is the legal issues affect the stock?
Q: Greetings team 5i,
Beside my core portfolio, I invest about 5% of my money in a “fun” portfolio. It has not been much fun recently. I bought ABBV (at the top) in order to write covered calls and cash-secured uncovered puts.
These calls, written just out-of-the-money and puts written just in-the-money on Mondays with the expiry date on the Friday of the same week, have produced premiums ranging from $US0.81 to $US2.73 which happened this week.
Why is there such a wide range of premium prices and what do the higher premiums suggest?
Thank you.
Milan
Beside my core portfolio, I invest about 5% of my money in a “fun” portfolio. It has not been much fun recently. I bought ABBV (at the top) in order to write covered calls and cash-secured uncovered puts.
These calls, written just out-of-the-money and puts written just in-the-money on Mondays with the expiry date on the Friday of the same week, have produced premiums ranging from $US0.81 to $US2.73 which happened this week.
Why is there such a wide range of premium prices and what do the higher premiums suggest?
Thank you.
Milan
Q: ABBV share price has slumped from approx. $95 to $82.50 in the past 5 days. Marinol was recently approved by the FDA. ABBV currently has a Forward P/E ratio of 10.72. I understand that the industry's average Forward P/E is 15.85.
What is your view of this stock. Seems like it might be an opportune time to buy and play the marijuana angle from a safe distance.
The Webinar yesterday was great. I hope there are more. Thank you for your services.
What is your view of this stock. Seems like it might be an opportune time to buy and play the marijuana angle from a safe distance.
The Webinar yesterday was great. I hope there are more. Thank you for your services.
-
AbbVie Inc. (ABBV $210.40)
-
Becton Dickinson and Company (BDX $192.98)
-
Medtronic plc. (MDT $92.81)
-
Stryker Corporation (SYK $391.41)
Q: Hi Team, sold my shares of RHT this morning. Transferring remaining capital from sale to US RRSP for another healthcare name. Someone on T.V last night was screaming Medtronic for a buy ,from my own readings and research I see Stryker as a good choice. Between the 2 which has a better growth profile. Which would you choose. I own ABBV and BDX for a total healthcare exposure of 17%. I Thank-you in advance! Like usual,......Great work team! Sam
Q: Abbvie has not done well since my relatively recent purchase. Down approcimately 7%. Would you suggest selling and making another purchase in the same sector?
With appeciation.
Ed
With appeciation.
Ed
-
Gilead Sciences Inc. (GILD $112.97)
-
AbbVie Inc. (ABBV $210.40)
-
Johnson & Johnson (JNJ $177.17)
-
Medtronic plc. (MDT $92.81)
-
Pfizer Inc. (PFE $24.76)
Q: Recently, 5i has supported members' suggestions to switch out of JNJ into something else given the legal difficulties that JNJ faces. I generally like to hold indefinitely; given this anticipated time frame, and my preference for safety and a good/growing dividend, do you think I should switch as well? Do you view the alternatives I've listed as less or more risky than JNJ overall? Are there non-pharmaceutical alternatives in the US healthcare space that would provide an equally secure and growing dividend that you would recommend? Thank you.
-
AbbVie Inc. (ABBV $210.40)
-
Johnson & Johnson (JNJ $177.17)
-
Knight Therapeutics Inc. (GUD $6.50)
-
Savaria Corporation (SIS $20.83)
-
iShares U.S. Medical Devices ETF (IHI $62.15)
Q: Hello, I am looking to add IHI to the healthcare allocation of my portfolio (10%) but would like to sell one existing holding first. Current healthcare related holdings are JNJ, ABBV, GUD and SIS (although I have SIS filed under Industrials). My question: which of JNJ and ABBV would you advise selling? Thank-you.